Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jan 19, 2017
Insider Transaction Report
Form 4
Knapp Thomas J
General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-01-17+5,000→ 5,000 totalExercise: $1.81Exp: 2027-01-17→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F2]This stock option will vest in 16 equal, quarterly installments over four years beginning three months from the date of grant, so long as the Reporting Person remains in the company's continuous employ through the vesting period.